Singh, S.; Nehete, P.N.; Yang, G.; He, H.; Nehete, B.; Hanley, P.W.; Barry, M.A.; Sastry, K.J.
Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines 2014, 2, 686-706.
https://doi.org/10.3390/vaccines2040686
AMA Style
Singh S, Nehete PN, Yang G, He H, Nehete B, Hanley PW, Barry MA, Sastry KJ.
Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines. 2014; 2(4):686-706.
https://doi.org/10.3390/vaccines2040686
Chicago/Turabian Style
Singh, Shailbala, Pramod N. Nehete, Guojun Yang, Hong He, Bharti Nehete, Patrick W. Hanley, Michael A. Barry, and K. Jagannadha Sastry.
2014. "Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant" Vaccines 2, no. 4: 686-706.
https://doi.org/10.3390/vaccines2040686
APA Style
Singh, S., Nehete, P. N., Yang, G., He, H., Nehete, B., Hanley, P. W., Barry, M. A., & Sastry, K. J.
(2014). Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines, 2(4), 686-706.
https://doi.org/10.3390/vaccines2040686